No products in the cart.
Siltartoxatug Injection 10mg (Trinomab) – AR Grade Factory low price wholesale
$10.00
Trinomab Siltartoxatug Injection offers 10mg of active ingredient per 0.5ml vial. Manufactured by Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd., and approved under China NMPA S20250012. Designed exclusively for experimental and laboratory research. Supports wholesale and retail orders.?For wholesale prices, other specifications and uses, please consult our staff?
Description
Siltartoxatug (Trinomab) is an injectable monoclonal antibody used in advanced experimental research focused on targeted immunotherapies and molecular oncology. This formulation delivers a precise 10mg dose per 0.5ml vial, enabling controlled studies of receptor binding, immune response modulation, and tumor microenvironment interactions.
Produced by Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd., Siltartoxatug is approved by the China National Medical Products Administration (NMPA) under registration number S20250012. The product is strictly for research use only and not for clinical or human applications.
Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Siltartoxatug Injection (Trinomab) |
| Dosage Form | Injectable solution |
| Strength | 10mg per 0.5ml vial |
| Packaging | Single vial |
| Approval Number | S20250012 (China NMPA) |
| Product Code | 86985202000013 |
| Manufacturer | Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd. |
| Barcode | Not yet recorded |
| Intended Use | Laboratory research only |
| Storage Conditions | Store refrigerated at 2–8°C, protect from light |
Mechanism of Action & Research Applications
Siltartoxatug (Trinomab) functions as a humanized monoclonal antibody targeting specific cellular receptors. It is widely employed in research to explore:
Targeted immunotherapy mechanisms
Receptor-ligand interaction dynamics
Modulation of immune checkpoints
Antibody-dependent cellular cytotoxicity (ADCC)
Tumor microenvironment studies
This product supports oncology, immunology, and molecular biology research aiming to develop new therapeutic approaches.
Side Effects (For Reference Only in Models)
In laboratory models, Siltartoxatug may induce:
Immune cell modulation
Altered cytokine expression
Possible off-target effects under experimental conditions
These side effects are observed under controlled research settings and do not represent clinical safety data.
Disclaimer
Siltartoxatug Injection (Trinomab) is intended exclusively for laboratory and experimental research. It is not approved for human or veterinary medical use. Use must comply with local research and safety regulations.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 26 × 23 × 26 cm |
Q1: What is the main purpose of Siltartoxatug Injection (Trinomab)?
A1: Siltartoxatug Injection is mainly used for laboratory research to study targeted immunotherapy, receptor binding, and immune system modulation. For laboratory research use only.
Q2: What is the dosage form and strength of Siltartoxatug Injection?
A2: It is an injectable solution containing 10mg of active antibody per 0.5ml vial.
Q3: Can Siltartoxatug Injection be used in clinical treatment?
A3: No, it is strictly for experimental and laboratory research and is not intended for clinical or therapeutic use.
Q4: Who manufactures Siltartoxatug Injection (Trinomab)?
A4: Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd. manufactures this product.
Q5: How should Siltartoxatug Injection be stored?
A5: Store in a refrigerator at 2–8°C and protect from light.
Q6: Is Siltartoxatug Injection approved by any regulatory body?
A6: Yes, it is approved by the China National Medical Products Administration (NMPA) with the number S20250012.
Q7: Are bulk purchases available for Siltartoxatug Injection?
A7: Yes, both wholesale and retail orders are supported.
Q8: Are COA and SDS available for Siltartoxatug Injection?
A8: Yes, these documents can be provided upon request.
Q9: What research areas is Siltartoxatug Injection commonly used in?
A9: It is commonly used in oncology, immunology, and molecular biology research.
Q10: What side effects have been observed in research models?
A10: Immune modulation and altered cytokine profiles have been noted in controlled lab studies.
Related products
Ritonavir Tablets (Fushengtang) 100?mg – For Laboratory Research Use Only
Fushengtang Ritonavir Tablets deliver 100?mg of ritonavir per tablet. Packaged as 20 tablets per box. Approved under China NMPA registration H20254135. Intended exclusively for experimental research use. Wholesale and retail orders supported.?For wholesale prices, other specifications and uses, please consult our staff? $1.00Azvudine Tablets 1?mg ×?35 Tablets – Wholesale & Retail (For Research Use Only)
Azvudine Tablets (Jiebei’an) are 1?mg film tablets provided in bottles or boxes of 35 tablets. Manufactured by Beijing Xiehe Pharmaceutical Co., Ltd., approved under H20210035. Pharmaceutical-grade antiviral suitable for laboratory research applications. Wholesale and retail available.?For wholesale prices, other specifications and uses, please consult our staff? $2.00Transfer Factor Injection (Lyophilized Powder) 3mg – Immune Support Research
Lyophilized injectable Transfer Factor, formulated for immune-related scientific research and experimental use. Supplied as 3mg:100?g per vial × 10 per box. Laboratory-grade only.?For wholesale prices, other specifications and uses, please consult our staff?
$10.00Mycophenolate Mofetil Tablets 0.5g – For Laboratory Research Only
Mycophenolate Mofetil Tablets deliver 0.5g of active compound per tablet and are primarily used in immunosuppressive research. Each bottle contains 100 tablets. For research use only—not for human or veterinary application.?For wholesale prices, other specifications and uses, please consult our staff? $2.00
Reviews
There are no reviews yet.